BCL2 and colitis: Conversely, Zhang et al. [167] found that, in DSS-induced colitis mice, miR-223 agomir led to the downregulation of Bcl-2 and Bcl-xl as well as an alleviation of colonic inflammation through inhibiting IL-6/STAT3 pathway.